First Glimpse of 4-Year Follow-Up Data In Major Study of Youth on Cross-Sex Hormones
The abstract has been released, detailing generally positive psychological outcomes among youths treated for gender dysphoria with cross-sex hormones, but with 1 in 5 doing persistently poorly.
The authors of the nation’s largest study of youths given cross-sex hormones for gender dysphoria will present four-year follow-up data at the American Academy of Child and Adolescent Psychiatry (AACAP) meeting in Chicago in October. This hotly anticipated research follows a widely referenced—and criticized—paper that posted two-year follow-up data regarding the same group of youth in the New England Journal of Medicine in January 2023.
Keep reading with a 7-day free trial
Subscribe to Hazard Ratio: Benjamin Ryan to keep reading this post and get 7 days of free access to the full post archives.